ARWR vs SRE · rev $829.4M vs P/E 31, rev $13.70B
Arrowhead Pharmaceuticals Inc (ARWR) versus Sempra Energy (SRE) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Sempra Energy (SRE) is a utilities - diversified company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported SRE revenue for 2025-12-31 was $13.70B. Net income was $1.84B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
ARWR currently screens at market cap $10.59B. SRE currently screens at market cap $59.76B and trailing P/E 31.1.
Not investment advice. Open the ARWR and SRE stock pages for the full models.
Not investment advice.